Osaic Holdings
ALZN icon

Osaic Holdings’s Alzamend Neuro ALZN Stock Holding History

Osaic Holdings’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$7 – 7431
2024
Q4 		$7 Buy
+1
New +$13 ﹤0.01% 7350
2024
Q3 		– Sell
-1
Closed -$26 – 7396
2024
Q2 		$26 Hold
1
– – ﹤0.01% 7326
2024
Q1 		$66 Hold
1
– – ﹤0.01% 7068
2023
Q4 		$59 Hold
1
– – ﹤0.01% 7155
2023
Q3 		$237 Hold
1
– – ﹤0.01% 7125
2023
Q2 		$510 Hold
1
– – ﹤0.01% 7048
2023
Q1 		$425 Buy
+1
New +$752 ﹤0.01% 7161
2021
Q3 		– Hold
0
– – – 7159
2021
Q2 		– Hold
0
– – – 6971

Other funds holding ALZN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CSB
City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings's ALZN Position: Q1 2025 in Review

Osaic Holdings sold out of Alzamend Neuro (ALZN) in Q1 2025, closing a stake of 1 share — an estimated $7 sold.

Osaic Holdings first reported a position in ALZN in Q1 2023 and held it in 7 quarters. The position peaked at $510 in Q2 2023. 8 funds tracked by Wall St. Rank hold ALZN as of Q1 2025.

  • Osaic Holdings reported no remaining Alzamend Neuro position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 1 Alzamend Neuro share in Q1 2025, an estimated $7.
  • Osaic Holdings first reported a position in Alzamend Neuro in Q1 2023 and held it in 7 quarters.
  • Osaic Holdings's Alzamend Neuro position peaked at $510 in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Alzamend Neuro as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.